GlassScriptPhysician profile
David Bryan Nolte
NPI 1245860436
$4,919.27
in general payments reported to CMS, 2019-2025
42 companies · $3,194 in 2025
The $3,194 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $645 · 2022: $578 · 2023: $54.42 · 2024: $448 · 2025: $3,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,695.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $482.10 | 2021-2024 | |
| Ucb, INC. | $366.64 | 2024-2025 | Briviact, Nayzilam, Rystiggo |
| Harmony Biosciences LLC | $364.22 | 2022-2025 | |
| Lilly USA, LLC | $363.94 | 2021-2025 | Kisunla, Emgality |
| Catalyst Pharmaceuticals, INC. | $338.01 | 2024-2025 | |
| Lundbeck LLC | $270.38 | 2022-2025 | Vyepti |
| Jazz Pharmaceuticals INC. | $248.26 | 2024-2025 | |
| Biogen, INC. | $222.47 | 2025 | Vumerity, Tysabri, Avonex |
| Pfizer INC. | $186.23 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $182.54 | 2022-2025 | Ingrezza |
| Arbor Pharmaceuticals, INC. | $177.07 | 2021-2022 | |
| Amgen INC. | $145.43 | 2024-2025 | Uplizna |
| Emd Serono, INC. | $127.67 | 2025 | |
| Alexion Pharmaceuticals, INC. | $127.39 | 2025 | Ultomiris |
| Genentech USA, INC. | $125.61 | 2025 | Ocrevus, Ocrevus Zunovo |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nolte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.